Drug application
GRIFULVIN V (GRISEOFULVIN, MICROSIZE)
Drugs@FDA ANDA 062483 · VALEANT LUXEMBOURG
Key facts
| Drug name | GRIFULVIN V |
|---|---|
| Active ingredients | GRISEOFULVIN, MICROSIZE |
| Application type | ANDA |
| Application number | 062483 |
| Company | VALEANT LUXEMBOURG |
| Dosage forms | SUSPENSION, ORAL |
| Strength | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jan 26, 1984 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- No FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: